Search Results - "programmed death-ligand 1"

Immunotherapy in young adults with mature cystic ovarian Teratoma-Derived squamous cell carcinoma: a case series.

Luo, Jing¹ (AUTHOR), Gao, Yu-xia¹ (AUTHOR), He, Qian¹ (AUTHOR), Wang, Wen-xiang¹ (AUTHOR) wangwenxiang_2014@126.com

The current status and prospects of gut microbiota combined with PD-1/PD-L1 inhibitors in the treatment of colorectal cancer: a review.

Deng, Min¹ (AUTHOR), Li, Xiaoyu² (AUTHOR), Wu, Huiming¹ (AUTHOR) wuhuiming@sxmu.edu.cn, Xue, Dingwen¹ (AUTHOR), Wang, Yize³ (AUTHOR), Guo, Renkai¹ (AUTHOR), Cui, Yipeng¹ (AUTHOR), Jin, Chenfei¹ (AUTHOR), luo, Fei⁴ (AUTHOR) Surgeonluo@hotmail.com, Li, Huiyu¹ (AUTHOR) lihuiyu1978@sxmu.edu.cn

Positivity Rate of PD-L1 Expression and Its Clinical Significance in Vulvar Cancer: A Systematic Review and Meta-Analysis.

Flindris, Stefanos¹ (AUTHOR), Margioula-Siarkou, Crysoula^1,2 (AUTHOR), Chalitsios, Christos V.^2,3 (AUTHOR), Margioula-Siarkou, Georgia^1,4 (AUTHOR), Almperi, Emmanouela-Aliki^1,5 (AUTHOR), Almperis, Aristarchos^1,6 (AUTHOR), Styliara, Effrosyni^1,3 (AUTHOR), Flindris, Konstantinos^2,4 (AUTHOR), Paschopoulos, Minas^3,5 (AUTHOR), Navrozoglou, Iordanis^4,5 (AUTHOR), Tsilidis, Konstantinos K.^2,5,6 (AUTHOR), Dinas, Konstantinos^1,6 (AUTHOR), Petousis, Stamatios¹ (AUTHOR), Markozannes, Georgios^2,6 (AUTHOR) g.markozannes@imperial.ac.uk

Molecular Dynamics-Guided Repositioning of FDA-Approved Drugs for PD-L1 Inhibition with In Vitro Anticancer Potential.

Jiang, Dejun¹ (AUTHOR), Yoou, Myoung-Schook² (AUTHOR), Cho, Sungjoon³ (AUTHOR), Choi, Youngjin^3,4 (AUTHOR) ojchoi@hoseo.edu

N-glycosylation of PD-L1 modulates the efficacy of immune checkpoint blockades targeting PD-L1 and PD-1.

Kaufman, Bar¹ (AUTHOR), Abu-Ahmad, Muhammad¹ (AUTHOR), Radinsky, Olga¹ (AUTHOR), Gharra, Eman¹ (AUTHOR), Manko, Tal¹ (AUTHOR), Bhattacharya, Baisali¹ (AUTHOR), Gologan, Daniela¹ (AUTHOR), Erlichman, Nofar² (AUTHOR), Meshel, Tsipi² (AUTHOR), Nuta, Yoav² (AUTHOR), Cooks, Tomer¹ (AUTHOR), Elkabets, Moshe¹ (AUTHOR) moshee@bgu.ac.il, Ben-Baruch, Adit² (AUTHOR) aditbb@tauex.tau.ac.il, Porgador, Angel¹ (AUTHOR) angel@bgu.ac.il

Prognostic and predictive value of IDO expression in metastatic melanoma treated with Ipilimumab.

von Bubnoff, Dagmar¹ (AUTHOR), Schmitt, Christina² (AUTHOR), Goldinger, Simone M.³ (AUTHOR), Schadendorf, Dirk⁴ (AUTHOR), Kähler, Katharina C.⁵ (AUTHOR), Hafner, Christian⁶ (AUTHOR), Kramer, Nora² (AUTHOR), Fröhlich, Waltraud^7,8,9 (AUTHOR), Dummer, Reinhard³ (AUTHOR), Berking, Carola^7,8,9 (AUTHOR), Schliep, Stefan^7,8,9 (AUTHOR), Kirchberger, Michael C.^7,8,9 (AUTHOR), Heinzerling, Lucie^2,7,8,9 (AUTHOR) lucie.heinzerling@med.uni-muenchen.de

Lymph node macrophage-targeted interferon alpha boosts anticancer immune responses by regulating CD169-positive phenotype of macrophages.

Fukuda, Ryo¹ (AUTHOR), Fujiwara, Yukio² (AUTHOR), Maeda, Hitoshi^1,3 (AUTHOR), Pan, Cheng² (AUTHOR), Minayoshi, Yuki¹ (AUTHOR), Yano, Hiromu^2,4 (AUTHOR), Mizuta, Yuki¹ (AUTHOR), Takano, Mei¹ (AUTHOR), Yamada, Rin² (AUTHOR), Saito, Yoichi⁵ (AUTHOR), Hirata, Kenshiro⁶ (AUTHOR), Imoto, Shuhei⁶ (AUTHOR), Yamasaki, Keishi⁶ (AUTHOR), Oniki, Kentaro⁷ (AUTHOR), Saruwatari, Junji⁷ (AUTHOR), Otagiri, Masaki⁶ (AUTHOR), Watanabe, Hiroshi¹ (AUTHOR) hnabe@kumamoto-u.ac.jp, Komohara, Yoshihiro² (AUTHOR) ycomo@kumamoto-u.ac.jp, Maruyama, Toru¹ (AUTHOR) tomaru@gpo.kumamoto-u.ac.jp

Lactobacillus johnsonii JERA01 upregulates the production of Th1 cytokines and modulates dendritic cells-mediated immune response.

Si-Yeon Kim¹, Hong-Gu Joo^1,2 jooh@jejunu.ac.kr

Combination of epirubicin and cyclophosphamide for the treatment of advanced pulmonary sarcomatoid carcinoma: A case report and literature review.

Deng, Ruoyu¹ (AUTHOR), Lv, Jialing¹ (AUTHOR), Wang, Fang² (AUTHOR), Chen, Yanqiong¹ (AUTHOR), Wang, Junfeng¹ (AUTHOR), Wang, Lin¹ (AUTHOR), Mu, Lixia¹ (AUTHOR), Zhang, Zhijun¹ (AUTHOR), Zhang, Wen¹ (AUTHOR) zhangwen@kmmu.edu.cn, Zhang, Chao¹ (AUTHOR) zhangchao@kmmu.edu.cn

PD-1 regulates the anti-tumor immune function of macrophages through JAK2-STAT3 signaling pathway in colorectal cancer tumor microenvironment.

Jiang, Han^1,2 (AUTHOR), Pang, Jingjing¹ (AUTHOR), Li, Tengyue² (AUTHOR), Akofala, Atitso¹ (AUTHOR), Zhou, Xiaoxi³ (AUTHOR), Yi, Changhua⁴ (AUTHOR), Ning, Shangwei² (AUTHOR) ningsw@ems.hrbmu.edu.cn, Gao, Xu^1,5 (AUTHOR) gaoxu6712@163.com, Qiao, Yu¹ (AUTHOR) qiaoyuhmu@163.com, Kou, Jiayuan¹ (AUTHOR) jiayuankou1992@outlook.com

Prospective Multi-Institutional Observational Study of Retreatment with Anti-PD-1/PD-L1 Antibodies in Patients with Non-Small Cell Lung Cancer Previously Treated with Anti-PD-1/PD-L1 Plus Chemotherapy: NJLCG (North Japan Lung Cancer Group) Trial 1901.

Saito, Shin¹ (AUTHOR), Kawashima, Yosuke² (AUTHOR) yousukekawashima3@yahoo.co.jp, Tanaka, Hisashi³ (AUTHOR), Yoshimura, Naruo⁴ (AUTHOR), Tsukita, Yoko⁵ (AUTHOR), Saito, Ryota⁶ (AUTHOR), Nakagawa, Taku⁷ (AUTHOR), Inomata, Minehiko⁸ (AUTHOR), Nagashima, Hiromi⁹ (AUTHOR), Sugawara, Shunichi¹ (AUTHOR)

The Attractiveness of B7-H3 as a Target for Lung Cancer Treatment.

Papavassiliou, Kostas A.¹ (AUTHOR), Sofianidi, Amalia A.² (AUTHOR), Papavassiliou, Athanasios G.² (AUTHOR) papavas@med.uoa.gr

Neutrophil-to-lymphocyte ratio-based prognostic score can predict outcomes in patients with advanced non-small cell lung cancer treated with immunotherapy plus chemotherapy.

Liao, Shan¹ (AUTHOR), Sun, Huiying¹ (AUTHOR), Lu, Hao¹ (AUTHOR), Wu, Jiani¹ (AUTHOR), Wu, Jianhua¹ (AUTHOR), Wu, Zhe¹ (AUTHOR), Xi, Jingle¹ (AUTHOR), Liao, Wangjun^1,2 (AUTHOR) nfyyliaowj@163.com, Wang, Yuanyuan¹ (AUTHOR) doc_wang@126.com

A New Protein–Ligand Trapping System to Rapidly Screen and Discover Small-Molecule Inhibitors of PD-L1 from Natural Products.

Huang, Yazhuo¹ (AUTHOR), Sun, Senfeng^1,2 (AUTHOR), Yin, Runxin^1,3 (AUTHOR), Lin, Zongtao^1,2 (AUTHOR), Wang, Daidong^1,2 (AUTHOR), Wang, Wanwan^1,3 (AUTHOR), Fu, Xiangyu¹ (AUTHOR), Wang, Jing¹ (AUTHOR), Lei, Xinyu¹ (AUTHOR), Sun, Mimi³ (AUTHOR), Chen, Shizhong¹ (AUTHOR), Wang, Hong¹ (AUTHOR)

Downregulation of PD-L1 expression by Wnt pathway inhibition to enhance PD-1 blockade efficacy in hepatocellular carcinoma.

Shao, Yu-Yun^1,2,3 (AUTHOR), Wang, Han-Yu² (AUTHOR), Hsu, Hung-Wei² (AUTHOR), Wo, Rita Robin² (AUTHOR), Cheng, Ann-Lii^1,2,3,4 (AUTHOR), Hsu, Chih-Hung^1,2,3 (AUTHOR) chihhunghsu@ntu.edu.tw

Predicting PD-L1 status in NSCLC patients using deep learning radiomics based on CT images.

Lu, Jiameng^1,2 (AUTHOR), Liu, Xinyi¹ (AUTHOR), Ji, Xiaoqing³ (AUTHOR), Jiang, Yunxiu¹ (AUTHOR), Zuo, Anli¹ (AUTHOR), Guo, Zihan¹ (AUTHOR), Yang, Shuran¹ (AUTHOR), Peng, Haiying⁴ (AUTHOR), Sun, Fei⁵ (AUTHOR), Lu, Degan¹ (AUTHOR) deganlu@126.com

Immunoinformatics based designing of a multi-epitope cancer vaccine targeting programmed cell death ligand 1.

Mahafujul Alam, Syed Sahajada¹ (AUTHOR), Mir, Showkat Ahmad² (AUTHOR), Samanta, Arijit¹ (AUTHOR), Nayak, Binata² (AUTHOR), Ali, Safdar³ (AUTHOR), Hoque, Mehboob^1,4 (AUTHOR) m_hoque@aliah.ac.in

The Role of Eosinophils, Eosinophil-Related Cytokines and AI in Predicting Immunotherapy Efficacy in NSCLC Cancer.

Omero, Fausto¹ (AUTHOR), Speranza, Desirèe^1,2 (AUTHOR), Murdaca, Giuseppe^2,3 (AUTHOR) giuseppe.murdaca@unige.it, Cavaleri, Mariacarmela^1,4 (AUTHOR), Marafioti, Mariapia^1,5 (AUTHOR), Cianci, Vincenzo^1,3 (AUTHOR), Berretta, Massimiliano^2,4 (AUTHOR), Casciaro, Marco^3,5 (AUTHOR), Gangemi, Sebastiano^4,5 (AUTHOR), Santarpia, Mariacarmela^1,5 (AUTHOR)

Soluble PD-L1: From Immune Evasion to Cancer Therapy.

Dragu, Denisa¹ (AUTHOR), Necula, Laura Georgiana^1,2 (AUTHOR), Bleotu, Coralia¹ (AUTHOR), Diaconu, Carmen C.^1,2 (AUTHOR), Chivu-Economescu, Mihaela¹ (AUTHOR)

DIAGNOSTIC AND PROGNOSTIC ROLE OF PDL1 EXPRESSION IN TUBERCULOUS PLEURAL EFFUSION: A COMPARATIVE STUDY WITH MALIGNANT EFFUSION.

Sinha, Jitendra Kumar¹ jitendrakumar.jk88@gmail.com, Manohar, L. Sarat¹